This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Dec 29;99(6A):31S-34S.

doi: 10.1016/s0002-9343(99)80283-6.

P-glycoprotein: its role in drug resistance

V Ling¹

Affiliations

PMID: 8585532
DOI: 10.1016/s0002-9343(99)80283-6

Review

P-glycoprotein: its role in drug resistance

V Ling. Am J Med. 1995.

. 1995 Dec 29;99(6A):31S-34S.

doi: 10.1016/s0002-9343(99)80283-6.

Author

V Ling¹

Affiliation

¹ British Columbia Cancer Research Centre, Vancouver, Canada.

PMID: 8585532
DOI: 10.1016/s0002-9343(99)80283-6

No abstract available

PubMed Disclaimer

Similar articles

P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Germann UA. Germann UA. Eur J Cancer. 1996 Jun;32A(6):927-44. doi: 10.1016/0959-8049(96)00057-3. Eur J Cancer. 1996. PMID: 8763334 Review. No abstract available.
Biology of the multidrug resistance-associated protein, MRP.
Loe DW, Deeley RG, Cole SP. Loe DW, et al. Eur J Cancer. 1996 Jun;32A(6):945-57. doi: 10.1016/0959-8049(96)00046-9. Eur J Cancer. 1996. PMID: 8763335 Review. No abstract available.
Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance.
Twentyman PR, Versantvoort CH. Twentyman PR, et al. Eur J Cancer. 1996 Jun;32A(6):1002-9. doi: 10.1016/0959-8049(96)00067-6. Eur J Cancer. 1996. PMID: 8763341 Review. No abstract available.
Transporter molecules in multidrug resistance.
Scheper RJ, Scheffer GL, Flens MJ, van der Valk P, Broxterman HJ, Izquierdo MA. Scheper RJ, et al. Cytotechnology. 1996;19(3):187-90. doi: 10.1007/BF00744211. Cytotechnology. 1996. PMID: 8862005 Review. No abstract available.
Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers.
Ford JM. Ford JM. Eur J Cancer. 1996 Jun;32A(6):991-1001. doi: 10.1016/0959-8049(96)00047-0. Eur J Cancer. 1996. PMID: 8763340 Review. No abstract available.

See all similar articles

Cited by

Mechanisms of the penetration of blood-borne substances into the brain.
Ueno M. Ueno M. Curr Neuropharmacol. 2009 Jun;7(2):142-9. doi: 10.2174/157015909788848901. Curr Neuropharmacol. 2009. PMID: 19949573 Free PMC article.
Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers.
Zhang Y, Benet LZ. Zhang Y, et al. Pharm Res. 1998 Oct;15(10):1520-4. doi: 10.1023/a:1011990730230. Pharm Res. 1998. PMID: 9794492
To use MIBI or not to use MIBI? That is the question when assessing tumour cells.
Moretti JL, Hauet N, Caglar M, Rebillard O, Burak Z. Moretti JL, et al. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):836-42. doi: 10.1007/s00259-005-1840-x. Eur J Nucl Med Mol Imaging. 2005. PMID: 15902437
MDR1 hypermethylation contributes to the progression of neuroblastoma.
Qiu YY, Mirkin BL, Dwivedi RS. Qiu YY, et al. Mol Cell Biochem. 2007 Jul;301(1-2):131-5. doi: 10.1007/s11010-006-9404-3. Epub 2007 Mar 27. Mol Cell Biochem. 2007. PMID: 17387584
Clinical pharmacokinetics of vinorelbine.
Levêque D, Jehl F. Levêque D, et al. Clin Pharmacokinet. 1996 Sep;31(3):184-97. doi: 10.2165/00003088-199631030-00003. Clin Pharmacokinet. 1996. PMID: 8877249 Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.